Graham DY and Gisbert JP |
Letter: clarithromycin dose for H. pylori therapy remains unresolved. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26238583
|
Jeong BH et al. |
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. |
2015 |
Am. J. Respir. Crit. Care Med. |
pmid:25393520
|
Yu T et al. |
Study on clarithromycin lactobionate based dual selector systems for the enantioseparation of basic drugs in capillary electrophoresis. |
2015 |
J Sep Sci |
pmid:26097042
|
Trotti LM et al. |
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. |
2015 |
Ann. Neurol. |
pmid:26094838
|
Townsell MY et al. |
Pathology in practice. Canine distemper virus disease in a dog. |
2015 |
J. Am. Vet. Med. Assoc. |
pmid:25719842
|
Scherübl H et al. |
[What is new in treating Helicobacter pylori infection?]. |
2015 |
Dtsch. Med. Wochenschr. |
pmid:25704525
|
Amiri M |
Impact of Helicobacter pylori Eradication Therapy on Platelet Counts in Patients With Chronic Idiopathic Thrombocytopenic Purpura. |
2015 |
Glob J Health Sci |
pmid:26925898
|
Park JB et al. |
Modulation of microenvironmental pH and utilization of alkalizers in crystalline solid dispersion for enhanced solubility and stability of clarithromicin. |
2015 |
Arch. Pharm. Res. |
pmid:25213008
|
Anton E et al. |
Randomized Trial of Clarithromycin for Mediterranean Spotted Fever. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711765
|
Winters N et al. |
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment. |
2015 |
Eur. Respir. J. |
pmid:26381514
|
Parra D et al. |
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions. |
2015 |
BMC Microbiol. |
pmid:26518881
|
Xing J et al. |
The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans. |
2015 |
Anal. Chim. Acta |
pmid:26515003
|
Agrawal V et al. |
A Case of Hypotension and Bradycardia Precipitated by Drug Interaction of Clarithromycin and Calcium-Channel Blocker. |
2015 |
J Am Geriatr Soc |
pmid:26389998
|
Stjepanovic MI et al. |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report. |
2016 |
Infez Med |
pmid:28011973
|
Muñoz-Egea MC et al. |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria. |
2016 |
Microb. Drug Resist. |
pmid:26208145
|
Salimi A et al. |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. |
2016 |
Xenobiotica |
pmid:26068526
|
Liou JM et al. |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. |
2016 |
Lancet |
pmid:27769562
|
Campillo A et al. |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. |
2016 |
Gastroenterol Hepatol |
pmid:27084668
|
Chauffour A et al. |
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. |
2016 |
PLoS Negl Trop Dis |
pmid:27755552
|
Abuhammour A et al. |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients. |
2016 |
Arab J Gastroenterol |
pmid:27665525
|
Matsumoto H et al. |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. |
2016 |
Dig. Dis. Sci. |
pmid:27659671
|
Rossi A et al. |
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations. |
2016 |
Drug Dev Ind Pharm |
pmid:26065531
|
Morimoto K et al. |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. |
2016 |
Ann Am Thorac Soc |
pmid:27513168
|
Christianson S et al. |
Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. |
2016 |
PLoS ONE |
pmid:27490181
|
Harada T et al. |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27489022
|
Okano Y et al. |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report. |
2016 |
BMC Pulm Med |
pmid:27287608
|
Steurer J |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect]. |
2016 |
Praxis (Bern 1994) |
pmid:27269781
|
Chung JW et al. |
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. |
2016 |
Dig Liver Dis |
pmid:27257049
|
Mitchell H and Katelaris P |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. |
2016 |
Med. J. Aust. |
pmid:27256648
|
Ullah S et al. |
Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. |
2016 |
Drug Deliv |
pmid:27247018
|
Parize P et al. |
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25677464
|
Huynh VA et al. |
[Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]. |
2016 |
Ann Dermatol Venereol |
pmid:27080820
|
EmiralioÄŸlu N et al. |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome. |
2016 |
J. Trop. Pediatr. |
pmid:27080471
|
Graham DY and Dore MP |
Helicobacter pylori therapy: a paradigm shift. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27077447
|
Song ZQ et al. |
Hybrid Therapy Regimen for Helicobacter Pylori Eradication. |
2016 |
Chin. Med. J. |
pmid:27064046
|
Matsumoto H et al. |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. |
2016 |
Helicobacter |
pmid:27061611
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Chua CS et al. |
The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial. |
2016 |
Int J Food Sci Nutr |
pmid:26883189
|
Meng X et al. |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province]. |
2016 |
Zhonghua Yi Xue Za Zhi |
pmid:26879786
|
Bakshi SS |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. |
2016 |
J Laryngol Otol |
pmid:26878377
|
Franceschi F et al. |
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:26875899
|
Tepeš B et al. |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. |
2016 |
Eur J Gastroenterol Hepatol |
pmid:26862930
|
Thung I et al. |
Review article: the global emergence of Helicobacter pylori antibiotic resistance. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26694080
|
Vermeer LM et al. |
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. |
2016 |
Drug Metab. Dispos. |
pmid:26668209
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Kamiya K et al. |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori. |
2016 |
J. Dermatol. |
pmid:26508502
|
Mark TM and Coleman M |
It's Time to Take Clarithromycin Seriously in Multiple Myeloma. |
2016 |
Acta Haematol. |
pmid:26505907
|
Qiu XH et al. |
Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells. |
2016 |
Acta Haematol. |
pmid:26505646
|
Lee J et al. |
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26373262
|
Tsujimae M et al. |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori. |
2016 |
Digestion |
pmid:28030862
|